Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
作者信息
Klaassen D J, Rapp E
出版信息
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):667-9.
PMID:4426046
Abstract
摘要
相似文献
1
Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):667-9.
2
Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).5-氮杂胞苷（NSC-102816）与洛莫司汀（CCNU，NSC-79037）治疗乳腺癌患者的比较及随后使用环磷酰胺（NSC-26271）的评估
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):677-81.
3
4
Lomustine treatment of metastatic renal cell carcinoma.
JAMA. 1973 Jul 2;225(1):32-5.
5
6
A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.1-（2-氯乙基）-3-（4-甲基环己基）-1-亚硝基脲治疗晚期胃肠道癌患者的试验
Br J Surg. 1974 Dec;61(12):950. doi: 10.1002/bjs.1800611206.
7
Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.亚硝基脲（环己亚硝脲，NSC - 79037）在晚期非血液系统癌症中的作用。
Cancer Chemother Rep. 1974 May-Jun;58(3):421-4.
8
9
Treatment of malignant melanoma with methyl CCNU.
Clin Pharmacol Ther. 1974 Jun;15(6):617-22. doi: 10.1002/cpt1974156617.
10
Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
Cancer. 1973 May;31(5):1164-9. doi: 10.1002/1097-0142(197305)31:5<1164::aid-cncr2820310519>3.0.co;2-4.
Zotero 插件